Karolinska Development's portfolio company OssDsign has received FDA clearance for a new major indication
STOCKHOLM, SWEDEN, September 19, 2023. Karolinska Development AB announces that its portfolio company OssDsign has received clearance from FDA for the use of OssDsign Catalyst in interbody cages in...
Source: marketscreener.com